Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
John Celebi
|
| gptkbp:focus |
immuno-oncology
cancer therapeutics |
| gptkbp:foundedYear |
1999
|
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:Rockville,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sensei Biotherapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:platform |
ImmunoPhage platform
|
| gptkbp:products |
SNS-101
SNS-301 |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
SNSE
|
| gptkbp:website |
https://www.senseibio.com/
|
| gptkbp:bfsParent |
gptkb:Cambrian_Biopharma
|
| gptkbp:bfsLayer |
7
|